Where does Alere SAN Diego, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Alere SAN Diego, Inc. ranks #11,906 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Alere SAN Diego, Inc. hold?

Alere SAN Diego, Inc. holds 25 US utility patents granted between 2015 and 2023, spanning 17 technology areas.

What is Alere SAN Diego, Inc.'s Innovation Score?

Alere SAN Diego, Inc. has an Innovation Score of 38.8 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Alere SAN Diego, Inc.'s patent grant rate increasing or decreasing?

Alere SAN Diego, Inc.'s recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Alere SAN Diego, Inc.'s patents?

Alere SAN Diego, Inc.'s patents average 19.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Alere SAN Diego, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Alere SAN Diego, Inc.

Q: What technology areas does Alere SAN Diego, Inc. focus on?

Alere SAN Diego, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 18 patents, ranking #264 of 2,502 assignees active in that subclass. Grants appear in 17 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 17 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alere ranks #11,906 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 17 technology areas.

#11,906
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.8/100): 19.7
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11906 · US Corporation #11,906 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #11,906/49,997
PHOTO-FINISH Adisseo France S
CPC-FOCUS C12Q · 17 areas
INNOV-THIN 38.8/100
CLAIMS-RICH 19.7 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adisseo France S.A.S. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Alere’s 38.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (29%) Velocity 1.1 pts (3%) Breadth 14.6 pts (38%) Claim depth 11.8 pts (30%)

Qualcomm Incorporated · highest

85
Alere SAN Diego · this assignee

39
Cynora · near

39
Immunocore · near

39
Institute OF… · near

39
Tarsus Pharmaceuticals · near

39
3D Lighting… · lowest

7

What this shows Alere's Innovation Score is 38.8/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Alere?

Each dot is one of Alere’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alere’s own 19.7 claims/patent is ABOVE the 17.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Alere vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Alere's grants concentrate

Alere SAN Diego, Inc. is a focused PatentsView assignee: 17 CPC subclasses with 72% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2023. By volume, Alere sits between Adisseo France S.A.S. and Apex Industrial Technologies LLC.

Alere's three-year grant acceleration

Alere SAN Diego, Inc. shows 1 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Adisseo France S

25
Agena Bioscience

25
Airspan Networks

25
Alcon Lensx

25
Alexza Pharmaceut…

25
Alza

25
Apator Miitors APS

25
Apex Industrial

25
Alere SAN Diego ◀

25

What this shows Alere holds 25 patents at rank #11,897, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alere

By rank, the assignees closest to #11,897 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Alere's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Alere, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Alere ranks #264 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Immunocore Limited 39 Cynora GmbH 39 Institute OF Pharmacology AND Toxicology, Academy OF Military Medical Sciences 39 Tarsus Pharmaceuticals, Inc. 39

Alere's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Alere SAN Diego, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	20.0%
2016	4	16.0%
2017	3	12.0%
2018	6	24.0%
2019	2	8.0%
2020	2	8.0%
2021	2	8.0%
2023	1	4.0%

Which technologies does Alere SAN Diego, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 18

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 18

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 7

C07K - Peptides 6

C12Y - Enzymes 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

C07D - Heterocyclic Compounds 4

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 3

C08L - Compositions OF Macromolecular Compounds 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

Top 15 of 17 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Alere SAN Diego, Inc.'s patent record in context - here's where to go next.

Alere SAN Diego, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 72% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #11,906 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Alere SAN Diego, Inc. against Adisseo France S.A.S., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.